Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has J. Scott Andrews's publication output changed over time?
ScholarIQpublication output · 2015–2024
Output grew100% over the shown period — from 1 works in 2015 to 2 in 2024.
1
1
1
3
1
1
1
2
20152016201820192020202220232024
What are the most-cited papers on J. Scott Andrews?
ScholarIQmost cited works
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf, Oskar Hansson, Carole Ho, William J. Jagust, Eric McDade, José Luís Molinuevo, Ozioma C. Okonkwo, Luca Pani, Michael S. Rafii, Philip Scheltens, Eric Siemers, Heather M. Snyder, Reisa A. Sperling, Charlotte E. Teunissen, Marı́a C. Carrillo
Alzheimer s & Dementia. 20242,424 CitationsOPEN ACCESS
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
J. Scott Andrews, Urvi Desai, Noam Y. Kirson, Miriam L. Zichlin, Daniel Ball, Brandy R. Matthews
S2898321583. 2019333 CitationsOPEN ACCESS
Expectations and clinical meaningfulness of randomized controlled trials
Ronald C. Petersen, Paul Aisen, J. Scott Andrews, Alireza Atri, Brandy R. Matthews, Dorene M. Rentz, Eric Siemers, Christopher J. Weber, María C. Carrillo
Alzheimer s & Dementia. 202392 CitationsOPEN ACCESS
Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1
R.L. Robinson, Dorene M. Rentz, J. Scott Andrews, Anthony J. Zagar, Yongin Kim, Valerie Bruemmer, Ronald L. Schwartz, Wenyu Ye, Howard Fillit
Journal of Alzheimer s Disease. 202072 CitationsOPEN ACCESS
Factors associated with long-term impact on informal caregivers during Alzheimer’s disease dementia progression: 36-month results from GERAS
Catherine Reed, Mark Belger, J. Scott Andrews, Antje Tockhorn‐Heidenreich, Roy Jones, Anders Wimo, Richard Dodel, Josep María Haro
International Psychogeriatrics. 201963 CitationsOPEN ACCESS
Related on ScholarIQ
Endo Pharmaceuticals (United States)
Institution
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Paper
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
Paper
Expectations and clinical meaningfulness of randomized controlled trials
Paper
Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1
Paper
Factors associated with long-term impact on informal caregivers during Alzheimer’s disease dementia progression: 36-month results from GERAS
Paper